Sage Therapeutics
SAGE
#7026
Rank
NZ$0.93 B
Marketcap
NZ$14.95
Share price
0.00%
Change (1 day)
7.82%
Change (1 year)

Market capitalization of Sage Therapeutics (SAGE)

Last known market cap: NZ$0.93 Billion

As of December 2025 Sage Therapeutics has a market cap of NZ$0.93 Billion. This makes Sage Therapeutics the world's 7026th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Sage Therapeutics from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$0.93 B56.16%
2024NZ$0.60 B-70.79%
2023NZ$2.05 B-42.44%
2022NZ$3.57 B-2.59%
2021NZ$3.66 B-47.5%
2020NZ$6.98 B25.67%
2019NZ$5.56 B-16.95%
2018NZ$6.69 B-30.59%
2017NZ$9.64 B252.12%
2016NZ$2.73 B11.59%
2015NZ$2.45 B105.14%
2014NZ$1.19 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Regulus Therapeutics
RGLS
NZ$0.97 B 3.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Eagle Pharmaceuticals
EGRX
NZ$11.15 M-98.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Horizon Therapeutics
HZNP
NZ$45.86 B 4,787.14%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Intercept Pharmaceuticals
ICPT
NZ$1.36 B 45.83%๐Ÿ‡บ๐Ÿ‡ธ USA